About the Journal
Journal of Vascular & Interventional Neurology is owned and published by Zeenat Qureshi Stroke Institute.
Journal of Vascular & Interventional Neurology is official journal of Zeenat Qureshi Stroke Institute (ZQSI) and Middle East North Africa Stroke and interventional Neurotherapies Organisation (MENA-SINO).
The journal is published every 3 months and has a total of 4 issues per year.
Authorship of the paper:
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. The journal follows the International Committee of Medical Journal Editors Criteria which recommends that authorship be based on the following 4 criteria:
• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
Disclosure and conflicts of interest:
All submissions must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal follows the International Committee of Medical Journal Editors policy. The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html
The International Committee of Medical Journal Editors Disclosure Form, may be used which declares:
• Authors’ relationships and activities; and
• Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; any restrictions regarding the submission of the report for publication; or a statement declaring that the supporting source had no such involvement or restrictions regarding publication; and
• Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is on-going.
The journal follows the International Committee of Medical Journal Editors policy. The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/responsibilities-in-the-submission-and-peer-peview-process.html
The Editor-in-Chief will ensure that appropriate reviewers are selected based on expertise and impartiality. The reviewers will have access to all materials that may be relevant to the evaluation of the manuscript. Reviewers will be asked prior to review if they have relationships or activities that could compromise their review. Reviewers must disclose to editors any relationships or activities that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists.
We perform single-blind review of submitted manuscripts. The authors’ identities and affiliations are known to reviewers. Making this information available to reviewers ensures that reviewers can identify any potential conflict of interest and recuse themselves if appropriate.
However authors can opt for double-blind review of manuscript on request at the time of submission of manuscript.
Originality, accuracy, scientific conduct, and plagiarism:
The journal does not publish manuscripts as a general policy describing essentially the same research as published in another journal. The authors should write the original works, and the work and/or words of others appropriately cited or quoted. Authors should be prepared to provide public access to the raw data in connection with a paper for editorial review.
Protection of research subjects, research animals and informed consent:
The journal follows the International Committee of Medical Journal recommendations for protection of human subjects. The policies are available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html. All investigators should ensure that the planning conduct and reporting of human research are in accordance with the Helsinki Declaration (2013 revision). All authors should seek approval to conduct research from an independent local, regional or national review body (e.g., ethics committee, institutional review board). The editors may form their own judgment whether the conduct of the research was appropriate. Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Patient consent should be written and archived with the authors, as dictated by local regulations or laws. Our journal does not archive the consent to avoid being aware of patient identity and patient confidentiality is better guarded by having the author archive the consent. When informed consent has been obtained, it should be indicated in the published article. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available at http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors.
Registration of Clinical Trials:
The journal follows the International Committee of Medical Journal recommendations (see http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html). Our journal requires registration of clinical trials in a public trials’ registry at or before the time of first patient enrollment as a condition of consideration for publication. We accept publicly accessible registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) that includes the minimum acceptable 24-item trial registration dataset or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP.
The journal follows the International Committee of Medical Journal recommendations. The data sharing statement policy is provided as follows: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html The Journal of Vascular and Interventional Neurology requires that report the results of clinical trials must contain a data sharing statement. Data sharing statements must indicate the following: whether individual de-identified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer); what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).
The journal follows the International Committee of Medical Journal recommendations for conduct, reporting, editing, and publication of scholarly work in medical journals. The policies are available at http://www.icmje.org/icmje-recommendations.pdf
Fees or charges:
The journal is one of very few public access journals that do not charge any fees or charges for manuscript processing and/or publishing materials in the journal for review. The journal and individual articles are available to readers without charges. The journal is supported by endowment from Zeenat Qureshi Stroke Institutes.
The journal permits advertisement of products with direct relevance to cerebrovascular diseases. The Editorial Board will decide the appropriateness of the content. Charges will apply to any advertisement.